Rising prevalence of benign prostatic hyperplasia is expected to drive growth of the prostatic artery embolization market over the forecast period.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |